Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8b81a5eda0046acaa7b584105a93cd52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e10ddd1d8677cf4e494fecd3b4759d82 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H21-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H21-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-1021 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-11 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-113 |
filingDate |
2015-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2017-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a568cfcbaa386af47814ecaeff64ed53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f377ef82daa343548f01f28361440cc4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f5d87d05f6178c2ecc9a8071cd26a19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09e72692d39c78559cb5ffbaeb168205 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29fbe713f662ba88b70dc3f66576bfcf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df30c50767019f0108043dad9b33dbe5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca66e3446cb81f846c728e4ba8ad78b7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b93e0572ede63e46c55b00f9e53d2564 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4943f7d3083f127a8da3c21d98e7419c |
publicationDate |
2017-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-9796756-B2 |
titleOfInvention |
Galactose cluster-pharmacokinetic modulator targeting moiety for siRNA |
abstract |
The present invention is directed compositions for targeted delivery of RNA interference (RNAi) polynucleotides to cell in vivo. The pharmacokinetic modulator improve in vivo targeting compared to the targeting ligand alone. Targeting ligand-pharmacokinetic modulator targeting moiety targeted RNAi polynucleotides can be administered in vivo alone or together with co-targeted delivery polymers. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021146548-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11702659-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022140702-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11766481-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11753638-B2 |
priorityDate |
2010-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |